Adjuvant trastuzumab for breast cancer: Editorial does not mention health economics of drugBMJ 2005; 331 doi: https://doi.org/10.1136/bmj.331.7526.1203 (Published 17 November 2005) Cite this as: BMJ 2005;331:1203
- E Hamish McLaren (email@example.com), retired consultant physician
- Badmany House, Beith, Ayrshire KA15 2JL
EDITOR—Why does the BMJ, which promotes itself as a journal dedicated to evidence based medicine, publish an editorial that talks only of the hazard ratio of a treatment without any reference to the absolute reduction in recurrence observed? …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial